Table 3.

Relative cell death values for the cisplatin/glibenclamide combination groups (Cis200: cisplatin 200 μM; G1, G10, and G50: glibenclamide 1, 10, and 50 μM, **p<0.01, ***p<0.001)

		n	Mean±SE	Median (25%–75%)	p*	Pairwise comparisons
1	Cis200	72	0.591±0.017	0.619 (0.497–0.701)	<0.001	1–5**, 2–5***, 1–7***, 4–7***, 1–6**, 3–6***, 1–3***
2	Cis200+G1	12	0.695±0.020	0.703 (0.648–0.737)
3	Cis200+G10	36	0.726±0.011	0.745 (0.685–0.769)
4	Cis200+G50	12	0.687±0.033	0.727 (0.590–0.770)
5	G1	9	0.233±0.048	0.177 (0.100–0.388)
6	G10	12	0.296±0.048	0.276 (0.153–0.439)
7	G50	23	0.274±0.038	0.231 (0.126–0.385)

^*Kruskal–Wallis one-way analysis of variance on ranks (median 25%–75%)